Seattle Genetics Begins Phase Ib study Of SGN-75 Combined With Everolimus RTT News (RTTNews) - Seattle Genetics Inc. (SGEN:Quote) has initiated a phase Ib clinical trial evaluating SGN-75 in combination with everolimus for patients with advanced metastatic renal cell carcinoma or RCC. The study is designed to assess the safety and ... Seattle Genetics commences everolimus-SGN-75 combination phase Ib clinical ... Seattle Genetics Announces Initiation Of A Phase Ib Trial Of SGN-75 In ... |
